Kitowski Nicole M
Known title: Executive Vice PresidentCIK: 0001721176
Associated companies
Transaction History
| ASB | ▼ Sell | Other | 25 | $755 | 9/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 23 | $755 | 8/17/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 6,255 | $193K | 7/28/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 1,408 | $44K | 7/28/2026 | View on chart |
| ASB | ▼ Sell | Other | 25 | $755 | 7/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 26 | $755 | 6/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 28 | $755 | 5/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 27 | $755 | 4/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 30 | $755 | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 11,477 | $288K | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 5,395 | $135K | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Other | 27 | $755 | 2/17/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,827 | $54K | 2/8/2026 | View on chart |
| ASB | ▲ Buy | Grant | 3,400 | $93K | 2/1/2026 | View on chart |
| ASB | ▼ Sell | Other | 27 | $733 | 1/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 27 | $733 | 12/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 29 | $733 | 11/17/2025 | View on chart |
| ASB | ▼ Sell | Other | 28 | $733 | 10/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 28 | $733 | 9/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 29 | $733 | 8/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 29 | $733 | 7/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 32 | $733 | 6/16/2025 | View on chart |
| ASB | ▼ Sell | Other | 30 | $733 | 5/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 37 | $733 | 4/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 33 | $733 | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 9,432 | $202K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 4,434 | $95K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Other | 29 | $734 | 2/18/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,095 | $53K | 2/10/2025 | View on chart |
| ASB | ▲ Buy | Grant | 3,639 | $0 | 1/29/2025 | View on chart |
| ASB | ▼ Sell | Other | 28 | $708 | 1/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 28 | $708 | 12/16/2024 | View on chart |
| ASB | ▼ Sell | Other | 27 | $708 | 11/15/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 8,741 | $227K | 11/7/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 18,082 | $438K | 11/7/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 22,000 | $484K | 11/7/2024 | View on chart |
| ASB | ▲ Buy | Option Exercise | 24,148 | $491K | 11/7/2024 | View on chart |
| ASB | ▼ Sell | Open Market | 72,971 | $2.0M | 11/7/2024 | View on chart |
| ASB | ▼ Sell | Other | 31 | $708 | 10/15/2024 | View on chart |
| ASB | ▼ Sell | Other | 33 | $708 | 9/16/2024 | View on chart |
| ASB | ▼ Sell | Other | 33 | $708 | 8/15/2024 | View on chart |
| ASB | ▼ Sell | Other | 32 | $708 | 7/15/2024 | View on chart |
| ASB | ▼ Sell | Other | 35 | $708 | 6/17/2024 | View on chart |
| ASB | ▼ Sell | Other | 32 | $708 | 5/15/2024 | View on chart |
| ASB | ▼ Sell | Open Market | 5,019 | $107K | 4/30/2024 | View on chart |
| ASB | ▼ Sell | Other | 35 | $708 | 4/15/2024 | View on chart |
| ASB | ▼ Sell | Other | 35 | $708 | 3/15/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 4,697 | $97K | 3/13/2024 | View on chart |
| ASB | ▲ Buy | Grant | 9,992 | $207K | 3/13/2024 | View on chart |
| ASB | ▼ Sell | Other | 35 | $708 | 2/15/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,122 | $42K | 2/9/2024 | View on chart |
| ASB | ▲ Buy | Grant | 3,973 | $0 | 1/30/2024 | View on chart |
| ASB | ▼ Sell | Other | 33 | $686 | 1/16/2024 | View on chart |
| ASB | ▼ Sell | Other | 32 | $686 | 12/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 38 | $686 | 11/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 42 | $686 | 10/16/2023 | View on chart |
| ASB | ▼ Sell | Other | 39 | $686 | 9/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 38 | $686 | 8/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 24 | $405 | 7/14/2023 | View on chart |
| ASB | ▼ Sell | Other | 7 | $123 | 6/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 8 | $123 | 5/15/2023 | View on chart |
| ASB | ▼ Sell | Other | 7 | $123 | 4/14/2023 | View on chart |
| ASB | ▼ Sell | Other | 6 | $123 | 3/15/2023 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,698 | $64K | 2/17/2023 | View on chart |
| ASB | ▼ Sell | Other | 5 | $123 | 2/15/2023 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,111 | $50K | 2/9/2023 | View on chart |
| ASB | ▲ Buy | Grant | 3,831 | $0 | 1/30/2023 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 4,065 | $92K | 1/27/2023 | View on chart |
| ASB | ▲ Buy | Grant | 8,031 | $181K | 1/26/2023 | View on chart |
| ASB | ▼ Sell | Other | 5 | $123 | 1/17/2023 | View on chart |
| ASB | ▼ Sell | Other | 5 | $120 | 12/15/2022 | View on chart |
| ASB | ▼ Sell | Other | 5 | $120 | 11/15/2022 | View on chart |
| ASB | ▼ Sell | Other | 5 | $120 | 10/17/2022 | View on chart |
| ASB | ▼ Sell | Other | 6 | $120 | 9/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.